Two in five Canadians will at some time be diagnosed with cancer and about one in four of us will die from the disease. Canadians need better access to effective new cancer drugs.

No one wants government drug plans to pay for expensive medicines if they have little clinical value, but Canadians with cancer want the opportunity to access new innovative drugs that may help them.